About Neocor Therapeutics
We are currently developing a novel gene therapy approach targeting ischemic and rare genetic cardiac diseases, and moving from lab preclinical trials to regulatory trials. The Company was founded in October and has received strong traction since inception. We will be looking to strengthen our human and financial ressources in the coming month in order to start the regulatory pre clinical trials.
- Employees
- 1 to 10
- Headquarters
- France
Leadership
The top of Neocor Therapeutics's org chart, with how many people report into each leader.
MM
Matthieu Metz
Chief Executive Officer
Jobs at Neocor Therapeutics
No open positions right now. Explore more companies on TheJobsMap.